All posts by: Michael Zand

About Michael Zand

What is CRISPR-Cas9? – Alphr

Continue reading

2017-07-24 NEWS

Alphr

What is CRISPR-Cas9?
Alphr
CRISPR-Cas9 is a genome editing tool that’s able to “cut” DNA in a targeted fashion, allowing scientists to accurately edit the building blocks of life. You’ll likely see it mentioned alongside the slightly-less-famous duo of CRISPR-Cas1 and CRISPR
Crispr Theraptc (CRSP) CEO Sells $166380.25 in StockSports Perspectives
Crispr Theraptc (NASDAQ:CRSP) Coverage Initiated at SunTrust Banks, Inc.Community Financial News
Kurt Von Emster Sells 81435 Shares of CRISPR THERAPTC (NASDAQ:CRSP) StockStock Observer
Chaffey Breeze –Breaking Finance News
all 8 news articles »
Continue reading

2017-07-23 NEWS

The San Diego Union-Tribune

Companies Rush to Develop ‘Utterly Transformative’ Gene Therapies
New York Times
Gene therapy for cancer is becoming a reality but works best for blood cancers like leukemia and not yet in more common ones like lung cancer.
Cancer stem cells target of new grant to UCSD scientists – The San …The San Diego Union-Tribune

all 2 news articles »

Continue reading

2017-07-23 NEWS

PhillyVoice.com

Cancer patients’ gray hair darkened on immunotherapy drugs
PhillyVoice.com
Chemotherapy is notorious for making hair fall out, but the 14 patients involved were all being treated with new immunotherapy drugs that work differently and have different side effects. A Spanish study suggests that may include restoring hair pigment
Cancer patients’ gray hair darkened on immune drugsNBC4i.com

all 33 news articles »